Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 6 | Immunity & Ageing

Fig. 6

From: Repeated COVID-19 mRNA vaccination results in IgG4 class switching and decreased NK cell activation by S1-specific antibodies in older adults

Fig. 6

Association between Fc-mediated effector functions and IgG4/IgG1 ratios or IgG avidity in older adults. The capacity of spike S1-specific serum antibodies to mediate ADNKA, ADCD and monocyte ADCP following mRNA vaccination in older adults (n = 38) at approximately 1 month after the third and fifth vaccinations relative to S1-specific total IgG levels at the same timepoint. Color scales indicate the IgG4/IgG1 ratio (A) or avidity index (B) of the SARS-CoV-2 spike S1-specific antibodies. Dotted lines indicate the level of the negative control (pre-pandemic serum sample). Solid grey lines were made using linear regression (straight lines) or locally estimated scatterplot smoothing (LOESS). SARS-CoV-2-infected individuals (based on N seropositivity) are indicated with open circles. ADCD, antibody-dependent complement deposition; ADCP, antibody-dependent cellular phagocytosis; ADNKA, antibody-dependent natural killer cell activation; BAU, binding antibody units; iMFI, integrated median fluorescence intensity; N, nucleoprotein

Back to article page

Immunity & Ageing

ISSN: 1742-4933

Contact us